| Rosemary Ann Senjem, MA LAMFT | |
|
305 Greeley St S Ste 105, Stillwater, MN 55082-7029 | |
| (651) 337-1038 | |
| (651) 337-1038 |
| Full Name | Rosemary Ann Senjem |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 305 Greeley St S Ste 105, Stillwater, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063012839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 4033 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary Ann Senjem, MA LAMFT 305 Greeley St S Ste 105, Stillwater, MN 55082-7029 Ph: (651) 571-2008 | Rosemary Ann Senjem, MA LAMFT 305 Greeley St S Ste 105, Stillwater, MN 55082-7029 Ph: (651) 337-1038 |
News Archive
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer.
Rectal cancer is more likely to spread to the lymph nodes in younger patients, according to new findings that Fox Chase Cancer Center researchers will be presenting on October 29 at the American Society for Radiation Oncology's 54th Annual Meeting.
EDAP TMS SA the global leader in therapeutic ultrasound, reported today successful completion of the first phase of the clinical protocol aimed at evaluating High Intensity Focused Ultrasound (HIFU) technology in patients with metastatic liver cancer. HIFU has the potential to destroy liver tumors through ablation and to reduce bleeding during surgery.
In a biological rendition of fiction's Strange Case of Dr. Jekyll and Mr. Hyde, researchers from the Mayo Clinic campus in Florida and Harvard Medical School have found that a protein thought to protect against cancer development can actually spur the spread of tumors.
› Verified 5 days ago
Diane M Cragoe, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 1875 Northwestern Ave S, Stillwater, MN 55082 Phone: 651-439-4840 Fax: 651-439-4840 | |
Jonathan Boorman, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 1875 Northwestern Ave S, Stillwater, MN 55082 Phone: 651-439-4840 | |
Rachel Ruth Dowling, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1875 Northwester Avenue South, Stillwater, MN 55082 Phone: 165-178-9403 Fax: 651-439-4894 | |
Shante Basant, LMFT, RN Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5995 Oren Ave N Ste 209, Stillwater, MN 55082 Phone: 612-524-9237 Fax: 612-314-8317 | |
Barbara Jean Shock Lemire, MA, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 1751 Tower Dr W, Stillwater, MN 55082 Phone: 651-439-2059 | |
Lambers B Fisher Jr., MS, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 1751 Tower Dr W Ste 200, Stillwater, MN 55082 Phone: 651-439-2059 Fax: 888-675-8262 |